Dr. Sarah Eliuth Ochoa Hugo | Nanomedicine | Young Scientist Award
Dr. Sarah Eliuth Ochoa Hugo at Center of Research and Assistance in Technology and Design of the State of Jalisco| Mexico
Dr. Sarah Eliuth Ochoa Hugo is a dedicated pharmaceutical chemist, biotechnologist, and researcher specializing in medical and pharmaceutical innovation. Currently pursuing her Ph.D. in Biotechnological Innovation Applied to Health at CIATEJ, she integrates her expertise in biotechnology, nanotechnology, and pharmacology to address critical challenges in cancer, Alzheimer’s disease, and medical device safety. As a lecturer at Universidad del Valle de México, she mentors future health professionals, guiding them in scientific research and publication. Alongside academia, she engages in entrepreneurial initiatives that merge scientific innovation with social impact, demonstrating her commitment to advancing healthcare through research, education, and applied technology.
Publication Profile
Orcid
Education
Dr. Sarah Eliuth Ochoa Hugo is currently a Ph.D. candidate in Biotechnological Innovation Applied to Health at CIATEJ, focusing on advanced biomedical solutions. She previously earned her Master of Science in Biotechnological Innovation Applied to Medical and Pharmaceutical Sciences at CIATEJ, where her thesis explored exosomal cargo in Alzheimer’s pathogenesis. Her academic foundation was built at Universidad del Valle de México, where she completed a Bachelor of Science in Pharmaceutical Chemistry and Biotechnology. There, she validated a 3D glioblastoma multiforme culture model. Complementing her degrees, she has completed certifications in pharmaceutical regulation, medical English, cancer biology, pharmacology, and advanced English proficiency.
Experience
Dr. Sarah Eliuth Ochoa Hugo serves as an undergraduate lecturer in Health Sciences at Universidad del Valle de México, where she promotes research-oriented learning and student publications. She is co-founder of Quality Approvers, a startup advancing process optimization using Lean and Six Sigma methodologies. Previously, she worked as a Pharmaceutical Chemist and Assistant Sanitary Responsible at San Javier Hospital, ensuring pharmaceutical compliance and safety. During the pandemic, she launched Paihuenk, a social entrepreneurship project producing artisanal cosmetics to support local communities. With extensive academic and industry experience, she bridges biomedical research, pharmaceutical practice, and innovation-driven entrepreneurship in health and biotechnology.
Awards and Honors
Dr. Sarah Eliuth Ochoa Hugo achievements are reflected through her strong academic and research portfolio, including international presentations at the Society for Neuroscience meetings in San Diego and publications in prominent journals. Her certification by COFEPRIS in pharmaceutical dispensing underscores her compliance with industry standards, while academic training from King’s College London, Monash University, and Johns Hopkins has expanded her global expertise. At Universidad del Valle de México, she has been recognized for her excellence in teaching, demonstrated. Her contributions to translational research and community-focused entrepreneurship highlight her growing academic influence.
Research Focus
Dr. Sarah Eliuth Ochoa Hugo research focuses on cancer therapy, Alzheimer’s disease, and medical device vigilance through biotechnological innovation. She has explored 3D glioblastoma culture models, evaluated phenolic compounds for anticancer activity, and investigated exosomal cargo in Alzheimer’s disease. Her recent work integrates nanotechnology, particularly gold nanostructures, for photothermal therapies in colon cancer. Additionally, she contributes to medical device monitoring and pharmaceutical safety through technovigilance research. Her multidisciplinary approach combines molecular biology, pharmacology, and nanomedicine, aiming to design innovative therapies with clinical applications. By integrating biotechnology with applied health sciences, her work advances precision medicine, preventive care, and translational biomedical innovation.
Publication Top Notes
Chemophotothermal Combined Therapy with 5-Fluorouracil and Branched Gold Nanoshell Hyperthermia Induced a Reduction in Tumor Size in a Xenograft Colon Cancer Model
Chemophotothermal Combined Therapy with 5- Fluorouracil and Branched Gold Nanoshell Hyperthermia Induced Reduction in Tumor Size in a Xenograft Colon Cancer Model
Consideraciones estadísticas en los ensayos de investigación preclínica
Hipertermia en cáncer de colon: terapia fototérmica con nanocorazas de oro
Tecnovigilancia: el monitoreo de los dispositivos médicos
In vitro evaluation of adjuvant therapy with hyperthermia induced by irradiation of AuNPs and Icg in tumor cells
Estandarización de un tratamiento quimio-fototérmico in vitro sobre células de cáncer colon
Panorama del cáncer de colon en México
Estandarización de un tratamiento de hipertermia más quimioterapia y evaluación de la citotoxicidad in vitro sobre células de cáncer de colon
Conclusion
Dr. Sarah Eliuth Ochoa Hugo embodies the qualities of an outstanding candidate for the Young Scientist Award. Her academic excellence, diverse research outputs, innovative spirit, and mentorship in health sciences collectively underscore her potential to become a leading figure in biomedical research. With continued focus on international exposure, targeted specialization, and expanded leadership in translational projects, she is not only deserving of recognition but also positioned to drive future breakthroughs in biotechnological innovation for global health.